Product Details for ANDA 202289
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM)
12.5MG;50MG
Marketing Status: Prescription
12.5MG;100MG
Marketing Status: Prescription
25MG;100MG
Marketing Status: Prescription
12.5MG;50MG
Marketing Status: Prescription
Active Ingredient: HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Proprietary Name: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202289
Product Number: 001
Approval Date: Aug 9, 2012
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM)
Proprietary Name: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202289
Product Number: 001
Approval Date: Aug 9, 2012
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
12.5MG;100MG
Marketing Status: Prescription
Active Ingredient: HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Proprietary Name: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202289
Product Number: 002
Approval Date: Aug 9, 2012
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM)
Proprietary Name: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202289
Product Number: 002
Approval Date: Aug 9, 2012
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
25MG;100MG
Marketing Status: Prescription
Active Ingredient: HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Proprietary Name: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202289
Product Number: 003
Approval Date: Aug 9, 2012
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202289
Product Number: 003
Approval Date: Aug 9, 2012
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status: Prescription
Patent and Exclusivity Information